TrialMedical oncology (Northwood, London, England)2015

A multi-center randomized phase II clinical study of bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) compared with FOLFIRI alone as second-line treatment for Chinese patients with metastatic colorectal cancer.

Ranhua Cao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.